IlluMyFi - Coloplast Lowers Annual Growth Ambition to 5%-7% Toward FY 2029/30

Burnit Learn

LOGIN REGISTER

BUSINESS CURRENCIES

Coloplast Lowers Annual Growth Ambition to 5%-7% Toward FY 2029/30

For FY 2026/27, it expects 5%-7% organic revenue growth and an EBIT margin of about 25% in constant currencies before special items.

econotimes.com 02-11-2026 05:29 0.5 Minutes reading

Sentiment Bullish · 75/100

BearishBullish